MSB 2.51% 97.0¢ mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-239

  1. 104 Posts.
    lightbulb Created with Sketch. 11
    I think this will be th corporate update. FDA don't want stem cells same as biotron because both treatments work and there is no money in cures FDA get f*ed
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.